Parthenon LLC’s Edwards Lifesciences EW Stock Holding History

Parthenon LLC’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$229K	Hold	2,526	–	–	0.02%	121
2026 Q1	$202K	Hold	2,526	–	–	0.02%	126
2025 Q4	$215K	Buy	+2,526	New	+$207K	0.02%	126
2024 Q3	–	Sell	-2,526	Closed	-$233K	–	126
2024 Q2	$233K	Hold	2,526	–	–	0.03%	115
2024 Q1	$241K	Buy	+2,526	New	+$212K	0.03%	112
2022 Q3	–	Sell	-2,112	Closed	-$201K	–	109
2022 Q2	$201K	Hold	2,112	–	–	0.03%	111
2022 Q1	$249K	Hold	2,112	–	–	0.04%	106
2021 Q4	$274K	Hold	2,112	–	–	0.04%	106
2021 Q3	$239K	Hold	2,112	–	–	0.04%	112
2021 Q2	$219K	Buy	+2,112	New	+$199K	0.03%	118

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

Parthenon LLC's EW Position: Q2 2026 in Review

Parthenon LLC held its Edwards Lifesciences (EW) position steady in Q2 2026 at 2,526 shares worth $229K. The position accounts for 0.02% of the portfolio, ranked #121.

Parthenon LLC first reported a position in EW in Q2 2021 and has held it in 10 quarters since. The position peaked at $274K in Q4 2021. 563 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Parthenon LLC held 2,526 shares of Edwards Lifesciences worth $229K as of Q2 2026.
Parthenon LLC left its Edwards Lifesciences share count unchanged in Q2 2026.
Edwards Lifesciences made up 0.02% of Parthenon LLC's portfolio in Q2 2026, its #121 holding.
Parthenon LLC first reported a position in Edwards Lifesciences in Q2 2021 and has held it in 10 quarters since.
Parthenon LLC's Edwards Lifesciences position peaked at $274K in Q4 2021.
563 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Parthenon LLC's 13F filing for Q2 2026, filed 23 Jul 2026.